By ‘red-flagging’ prescriptions that come from telehealth providers in other states, the proposed DEA rules may “inadvertently create barriers to care,” said Joseph Kvedar, MD. In this piece, he discusses recommendations from the ATA to help build pharmacists’ trust in filling remote prescriptions.